Skip to main content
SpringerLink
Log in

Dermatologic Mimickers of Breast Lesions Arising in the Breast Skin, Subcutis, or Axilla

  • Chapter
  • First Online:
A Comprehensive Guide to Core Needle Biopsies of the Breast

  • 678 Accesses

Abstract

The subanatomical compartments of the breast, nipple, and axilla are located within close proximity to one another, resulting in an overlap of different histopathological regions. As a consequence, lesions of the skin, subcutaneous tissue, and fascia can present clinically as breast masses. Moreover, a breast neoplasm can be initially managed as a dermatological process. Clinical information, including radiologic imaging, is of critical importance in the evaluation of these lesions.

In limited biopsy samples, the distinction between mammary and non-mammary entities can be problematic, as these can share similar histomorphology. As the management of cutaneous and mammary neoplasms is vastly different, proper management depends on an accurate interpretation of this limited material.

In this chapter, we propose an algorithmic approach to the differential diagnosis of cutaneous mimics of breast neoplasms for the initial evaluation of needle biopsies. Relevant immunohistochemical stains and their patterns of expression are discussed. A review of cutaneous tumors reported to present in the breast and axilla is provided. These lesions are of sweat gland, surface epithelial, neuroendocrine, melanocytic, or mesenchymal derivation. The pertinent mammary differential diagnosis for each entity is discussed with an emphasis on possible diagnostic pitfalls and important clues to the diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hoda SA. Chapter 1: Anatomy and physiologic morphology. In: Rosen PP, editor. Breast pathology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2014. p. 1–26.

    Google Scholar 

  2. Kalli S, Freer PE, Rafferty EA. Lesions of the skin and superficial tissue at breast MR imaging. Radiographics. 2010;30:1891–913.

    PubMed  Google Scholar 

  3. Nicholson BT, Harvey JA, Cohen MA. Nipple-areolar complex: normal anatomy and benign and malignant processes. Radiographics. 2009;29:509–23.

    PubMed  Google Scholar 

  4. Giess CS, Raza S, Birdwell RL. Distinguishing breast skin lesions from superficial breast parenchymal lesions: diagnostic criteria, imaging characteristics, and pitfalls. Radiographics. 2011;31:1959–72.

    PubMed  Google Scholar 

  5. Sariya D, Ruth K, Adams-McDonnell R, et al. Clinicopathologic correlation of cutaneous metastases: experience from a cancer center. Arch Dermatol. 2007;143:613–20.

    PubMed  Google Scholar 

  6. Qureshi HS, Ormsby AH, Lee MW, et al. The diagnostic utility of p63, CK5/6, CK 7, and CK 20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas. J Cutan Pathol. 2004;31:145–52.

    PubMed  Google Scholar 

  7. Robson A, Lazar AJF, Nagi JB, et al. Primary cutaneous apocrine carcinoma: a clinico-pathologic analysis of 24 cases. Am J Surg Pathol. 2008;32(5):682–90.

    PubMed  Google Scholar 

  8. Mentrikoski M, Wick MR. Immunohistochemical distinction of primary sweat gland carcinoma and metastatic breast carcinoma. Can it always be accomplished reliably? Am J Clin Pathol. 2015;143:430–6.

    CAS  PubMed  Google Scholar 

  9. Rollins-Raval M, Chivukula M, Tseng GC, et al. An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature. Arch Pathol Lab Med. 2011;135:975–83.

    CAS  PubMed  Google Scholar 

  10. Piris A, Peng Y, Boussahmain C, et al. Cutaneous and mammary apocrine carcinomas have different immunoprofiles. Hum Pathol. 2014;45(2):320–6.

    CAS  PubMed  Google Scholar 

  11. Gloyeske NC, Woodard AH, Elishaev E, et al. Immunohistochemical profile of breast cancer with respect to estrogen receptor and HER2 status. Appl Immunohistochem Mol Morphol. 2015;23(3):202–8. https://doi.org/10.1097/PAI.0000000000000076.

    Article  CAS  PubMed  Google Scholar 

  12. Wick MR, Ockner DM, Mills SE, et al. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. Am J Clin Pathol. 1998;109(1):75–84.

    CAS  PubMed  Google Scholar 

  13. Fernandez-Flores A. Immunohistochemical and morphologic evaluation of primary cutaneous apocrine carcinomas and cutaneous metastases from ductal breast carcinoma. Romanian J Morphol Embryol. 2012;53(4):879–92.

    CAS  Google Scholar 

  14. Luo MH, Huang YH, Ni YB, et al. Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas. Hum Pathol. 2013;44(7):1241–50.

    CAS  PubMed  Google Scholar 

  15. Wendroth SM, Mentrikoski MJ, Wick MR. GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin. Ann Diagn Pathol. 2015;19(1):6–9.

    PubMed  Google Scholar 

  16. Krings G, Nystrom M, Mehdi I, et al. Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer. Hum Pathol. 2014;45(11):2225–32.

    CAS  PubMed  Google Scholar 

  17. Mettinen M, McCue PA, Sarlomo-Rikala M, et al. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol. 2014;38(1):13–22.

    Google Scholar 

  18. Lee JJ, Mochel MC, Piris A, et al. P40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases. Hum Pathol. 2014;45(5):1078–83.

    CAS  PubMed  Google Scholar 

  19. Busam KJ, Tan LK, Granter SR, et al. Epidermal growth factor, estrogen and progesterone receptor expression in primary sweat gland carcinomas ad primary and metastatic mammary carcinomas. Mod Pathol. 1999;12(8):786–93.

    CAS  PubMed  Google Scholar 

  20. Bayer-Garner IB, Smoller B. Androgen receptors: a marker to increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site. Mod Pathol. 2000;13(2):119–22.

    CAS  PubMed  Google Scholar 

  21. Le LP, Dias-Santagata D, Pawlak AC, et al. Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses. PLoS One. 2012;7(10):e47290.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Niemeier LA, Dabbs DJ, Beriwal S, et al. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation. Mod Pathol. 2010;23(2):205–12.

    CAS  PubMed  Google Scholar 

  23. Plaza JA, Ortega PF, Stockman DL, et al. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. J Cutan Pathol. 2010;37:403–10.

    PubMed  Google Scholar 

  24. Ivan D, Diwan AH, Prieto VG. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin. Mod Pathol. 2005;18:137–42.

    CAS  PubMed  Google Scholar 

  25. Plumb SJ, Argenyi ZB, Stone MS, et al. Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma. Am J Dermatopathol. 2004;26(6):447–51.

    PubMed  Google Scholar 

  26. Mahalingam M, Nguyen LP, Richards JE, et al. The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin. Mod Pathol. 2010;23(5):713–9.

    CAS  PubMed  Google Scholar 

  27. Kaufmann O, Fietze E, Mengs J, et al. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol. 2001;116:823–30.

    CAS  PubMed  Google Scholar 

  28. Reis-Filho JS, Simpson PT, Martins A, et al. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch. 2003;443:122–32.

    CAS  PubMed  Google Scholar 

  29. Carpenter PM, Wang-Rodriguez J, Chan OT, et al. Laminin 5 expression in metaplastic breast carcinomas. Am J Surg Pathol. 2008;32:345–53.

    PubMed  Google Scholar 

  30. Kim SK, Jung WH, Koo JS. p40 (ΔNp63) expression in breast disease and its correlation with p63 immunohistochemistry. Int J Clin Exp Pathol. 2014;7(3):1032–41.

    PubMed  PubMed Central  Google Scholar 

  31. Koker MM, Kleer CG. p63 expression in breast cancer. A highly sensitive and specific marker of metaplastic carcinoma. Am J Surg Pathol. 2004;28:1506–12.

    PubMed  Google Scholar 

  32. Ding Y, Ruan Q. The value of p63 and CK5/6 expression in the differential diagnosis of ductal lesions of breast. J Huazhong Univ Sci Technol Med Sci. 2006;26(4):405–7.

    CAS  Google Scholar 

  33. Cimino-Mathews A, Sharma R, Illei PB, et al. A subset of malignant phyllodes tumors express p63 and p40. A diagnostic pitfall in breast core needle biopsies. Am J Surg Pathol. 2014;38(12):1689–96.

    PubMed  PubMed Central  Google Scholar 

  34. Bishop JA, Teruya-Feldstein J, Westra WH, et al. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol. 2012;25(3):405–15.

    CAS  PubMed  Google Scholar 

  35. Alomari AK, Glusac EJ, McNiff JM. p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma. J Cutan Pathol. 2014;41(11):839–45.

    PubMed  Google Scholar 

  36. Ha Lan TT, Chen SJ, Arps DP, et al. Expression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinoma. J Cutan Pathol. 2014;41(11):831–8.

    PubMed  Google Scholar 

  37. Henderson SA, Torres-Cabala CA, Curry JL, et al. p40 is more specific than p63 for the distinction of atypical fibroxanthoma from other cutaneous spindle cell malignancies. Am J Surg Pathol. 2014;38(8):1102–10.

    PubMed  Google Scholar 

  38. D’Alfonso TM, Ross DS, Liu YF, et al. Expression of p40 and laminin 332 in metaplastic spindle cell carcinoma of the breast compared with other malignant spindle cell tumors. J Clin Pathol. 2015;68(7):516–21. https://doi.org/10.1136/jclinpath-2015-202923.

    Article  CAS  PubMed  Google Scholar 

  39. Gomaa AHA, Yaar M, Bhawan J. Cutaneous immunoreactivity of D2-40 antibody beyond the lymphatics. Am J Dermatopathol. 2007;29(1):18–21.

    PubMed  Google Scholar 

  40. Liang H, Wu H, Giorgadze TA, et al. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin. Am J Surg Pathol. 2007;31(2):304–10.

    PubMed  Google Scholar 

  41. Mhawech-Fauceglia P, Saxena R, Zhang S, et al. Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysis. J Clin Pathol. 2007;60:709–14.

    CAS  PubMed  Google Scholar 

  42. Varma S, Shin SJ. An algorithmic approach to spindle cell lesions of the breast. Adv Anat Pathol. 2013;20(2):95–109.

    PubMed  Google Scholar 

  43. Lee WJ, Chang SE, Lee MW, et al. Bilateral mucinous eccrine nevus in an adult. J Dermatol. 2008;35:552–4.

    PubMed  Google Scholar 

  44. Kawaoka JC, Gray J, Schappell D. Eccrine nevus. J Am Acad Dermatol. 2004;51:301–4.

    PubMed  Google Scholar 

  45. Morris ES, Scheel MM, Lundquist KF, et al. Grouped papules on the arm of an infant. Eccrine nevus. Arch Dermatol. 2000;136:549–52.

    CAS  PubMed  Google Scholar 

  46. Cunliffe WJ, Johnson CE, Williamson DM. Localized unilateral hyperhidrosis—a clinical and laboratory study. Br J Dermatol. 1972;86:374–8.

    CAS  PubMed  Google Scholar 

  47. Misago N, Narisawa Y. Syringocystadenoma papilliferum with extensive apocrine nevus. J Dermatol. 2006;33:303–5.

    PubMed  Google Scholar 

  48. Nishikawa Y, Tokusashi Y, Saito Y, et al. A case of adenocarcinoma associated with hamartomatous apocrine gland hyperplasia of both axillae. Am J Surg Pathol. 1994;18:832–6.

    CAS  PubMed  Google Scholar 

  49. Mehregan AH. Proliferation of sweat ducts in certain diseases of the skin. Am J Dermatopathol. 1981;3:27–31.

    CAS  PubMed  Google Scholar 

  50. Martorell-Calatayud A, Sanmartín O, Botella-Estrada R, et al. Chemotherapy-related bilateral dermatitis associated with eccrine squamous syringometaplasia: reappraisal of epidemiological, clinical, and pathological features. J Am Acad Dermatol. 2011;64(6):1092–103.

    PubMed  Google Scholar 

  51. Gallo E, Llamas-Velasco M, Navarro R, et al. Eccrine squamous syringometaplasia secondary to cutaneous extravasation of docetaxel: report of three cases. J Cutan Pathol. 2013;40(3):326–9.

    PubMed  Google Scholar 

  52. Teoh DC, Aw DC, Jaffar H, et al. Tamoxifen-induced eccrine squamous syringometaplasia. J Cutan Pathol. 2012;39:554–7.

    PubMed  Google Scholar 

  53. Jerasutus S, Laohabhan K, Suvanprakorn P. Primary squamous syringometaplasia with no underlying malignancy. Int J Dermatol. 1999;38:375–6.

    CAS  PubMed  Google Scholar 

  54. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994;30:774–8.

    CAS  PubMed  Google Scholar 

  55. Wade TR, Ackerman AB. The many faces of basal cell carcinoma. J Dermatol Surg Oncol. 1978;4:23–8.

    CAS  PubMed  Google Scholar 

  56. Salasche SJ, Amonette RA. Morpheaform basal-cell epitheliomas. A study of subclinical extensions in a series of 51 cases. J Dermatol Surg Oncol. 1981;7:387–94.

    CAS  PubMed  Google Scholar 

  57. Martin RC, Edwards MJ, Cawte TG, et al. Basosquamous carcinoma: analysis of prognostic factors influencing recurrence. Cancer. 2000;88:1365–9.

    PubMed  Google Scholar 

  58. Poniecka AW, Alexis JB. An immunohistochemical study of basal cell carcinoma and trichoepithelioma. Am J Dermatopathol. 1999;21:332–6.

    CAS  PubMed  Google Scholar 

  59. Fan YS, Carr RA, Sanders DS, et al. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma. Histopathology. 2007;51:80–6.

    CAS  PubMed  Google Scholar 

  60. Yu L, Galan A, McNiff JM. Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma. J Cutan Pathol. 2009;36:1074–6.

    PubMed  Google Scholar 

  61. Crowson AN, Magro CM, Kadin ME, et al. Differential expression of the BCL2 oncogene in human basal cell carcinoma. Hum Pathol. 1996;27:355–9.

    CAS  PubMed  Google Scholar 

  62. Yada K, Kashima K, Daa T, et al. Expression of CD10 in basal cell carcinoma. Am J Dermatopathol. 2004;26:463–71.

    PubMed  Google Scholar 

  63. Auepemkiate S, Boonyaphiphat P, Thongsuksai P. p53 expression related to the aggressive infiltrative histopathological feature of basal cell carcinoma. Histopathology. 2002;40:568–73.

    PubMed  Google Scholar 

  64. Yang HM, Cabral E, Dadras SS, Cassarino DS. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas. Am J Dermatopathol. 2008;30(6):549–54.

    PubMed  Google Scholar 

  65. Bryant J. Fibroepithelioma of Pinkus overlying breast cancer. Arch Dermatol. 1985;121(3):310.

    CAS  PubMed  Google Scholar 

  66. Avci O, Pabuççuoğlu U, Koçdor MA, et al. Basal cell carcinoma of the nipple—an unusual location in a male patient. J Dtsch Dermatol Ges. 2008;6(2):130–2.

    PubMed  Google Scholar 

  67. Katona TM, Ravis SM, Perkins SM, et al. Expression of androgen receptor by fibroepithelioma of Pinkus: evidence supporting classification as a basal cell carcinoma variant? Am J Dermatopathol. 2007;29:7–12.

    PubMed  Google Scholar 

  68. Bowen AR, LeBoit PE. Fibroepithelioma of Pinkus is a fenestrated trichoblastoma. Am J Dermatopathol. 2005;27:149–54.

    PubMed  Google Scholar 

  69. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med. 1992;327:1649–62.

    CAS  PubMed  Google Scholar 

  70. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26:976–90.

    CAS  PubMed  Google Scholar 

  71. Diaz-Cascajo C, Borghi S, Weyers W, et al. Follicular squamous cell carcinoma of the skin: a poorly recognized neoplasm arising from the wall of hair follicles. J Cutan Pathol. 2004;31:19–25.

    PubMed  Google Scholar 

  72. Morritt AN, Tiffin N, Brotherston TM. Squamous cell carcinoma arising in epidermoid cysts: report of four cases and review of the literature. J Plast Reconstr Aesthet Surg. 2012;65:1267–9.

    CAS  PubMed  Google Scholar 

  73. Taube JM, Badger J, Kong CS, et al. Differentiated (simplex) vulvar intraepithelial neoplasia: a case report and review of the literature. Am J Dermatopathol. 2011;33:e27–30.

    PubMed  Google Scholar 

  74. Pulitzer M, Desman G, Busam K. CK7 expression in primary cutaneous squamous cell carcinoma. J Cutan Pathol. 2010;37(9):966–72.

    PubMed  Google Scholar 

  75. Altaf FJ, Mokhtar GA, Emam E, et al. Metaplastic carcinoma of the breast: an immunohistochemical study. Diagn Pathol. 2014;9(1):139.

    PubMed  PubMed Central  Google Scholar 

  76. Doxtader EE, Katzenstein AL. The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases. Hum Pathol. 2012;43(3):327–32.

    CAS  PubMed  Google Scholar 

  77. Subhawong AP, Subhawong T, Nassar H. Most basal-like breast carcinomas demonstrate the same Rb−/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically. Am J Surg Pathol. 2009;33(2):163–75.

    PubMed  PubMed Central  Google Scholar 

  78. Headington JT. Tumors of the hair follicle: a review. Am J Pathol. 1976;85:480–505.

    Google Scholar 

  79. Rosen LB. A review and proposed new classification of benign acquired neoplasms with hair follicle differentiation. Am J Dermatopathol. 1990;12:496–516.

    CAS  PubMed  Google Scholar 

  80. Aloi F, Tomasini C, Pippione M. Pigmented trichoblastoma. Am J Dermatopathol. 1992;14:345–9.

    CAS  PubMed  Google Scholar 

  81. Brownstein MH, Shapiro L. The pilosebaceous tumors. Int J Dermatol. 1977;16:340–52.

    CAS  PubMed  Google Scholar 

  82. Troy JL, Ackerman AB. Sebaceoma. A distinctive benign neoplasm of adnexal epithelium differentiating towards sebaceous cells. Am J Dermatopathol. 1984;6:7–13.

    CAS  PubMed  Google Scholar 

  83. Burgdorf WHC, Pitha J, Fahmy A. Muir-Torre syndrome: histologic spectrum of sebaceous proliferations. Am J Dermatopathol. 1986;8:202–8.

    CAS  PubMed  Google Scholar 

  84. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol. 1995;33:90–104.

    CAS  PubMed  Google Scholar 

  85. Orta L, Klimstra DS, Qin J, et al. Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient’s age or other clinical characteristics. Am J Surg Pathol. 2009;33(6):934–44.

    PubMed  Google Scholar 

  86. Kurokawa I, Nishimura K, Hakamada A, et al. Rippled-pattern sebaceoma with an immunohistochemical study of cytokeratins. J Eur Acad Dermatol Venereol. 2007;21:133–4.

    CAS  PubMed  Google Scholar 

  87. Reis-Filho JS, Torio B, Albergaria A, et al. p63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol. 2002;29(9):517–23.

    PubMed  Google Scholar 

  88. Ansai S, Takeichi H, Arase S, et al. Sebaceous carcinoma: an immunohistochemical reappraisal. Am J Dermatopathol. 2011;33(6):579–87.

    PubMed  Google Scholar 

  89. Ansai S, Arase S, Kawana S, et al. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies. J Dermatol. 2011;38(10):951–8.

    PubMed  Google Scholar 

  90. Wick MR, Goellner JR, Wolfe JT III, et al. Adnexal carcinomas of the skin. II. Extraocular sebaceous carcinomas. Cancer. 1985;56:1163–72.

    CAS  PubMed  Google Scholar 

  91. Nelson BR, Hamlet KR, Gillard M, et al. Sebaceous carcinoma. J Am Acad Dermatol. 1995;33:1–15.

    CAS  PubMed  Google Scholar 

  92. Dasgupta T, Wilson LD, Yu JB. A retrospective review of 1349 cases of sebaceous carcinoma. Cancer. 2009;115:158–65.

    PubMed  Google Scholar 

  93. Wolfe JT III, Wick MR, Campbell RJ. Sebaceous carcinomas of the oculocutaneous adnexa and extraocular skin. In: Wick MR, editor. Pathology of unusual malignant cutaneous tumors. New York: Marcel Dekker; 1985. p. 77–106.

    Google Scholar 

  94. Murakami A, Kawachi K, Sasaki T, et al. Sebaceous carcinoma of the breast. Pathol Int. 2009;59(3):188–92.

    PubMed  Google Scholar 

  95. Cibull TL, Thomas AB, Badve S, et al. Sebaceous carcinoma of the nipple. J Cutan Pathol. 2008;35(6):608–10.

    PubMed  Google Scholar 

  96. Sramek B, Lisle A, Loy T. Immunohistochemistry in ocular carcinomas. J Cutan Pathol. 2008;35:641–6.

    PubMed  Google Scholar 

  97. Suster S. Clear cell tumors of the skin. Semin Diagn Pathol. 1996;13:40–59.

    CAS  PubMed  Google Scholar 

  98. Kariya Y, Moriya T, Suzuki T, et al. Sex steroid hormone receptors in human skin appendage and its neoplasms. Endocr J. 2005;52(3):317–25.

    CAS  PubMed  Google Scholar 

  99. Cho KJ, Khang SK, Koh JS, et al. Sebaceous carcinoma of the eyelids: frequent expression of c-erbB-2 oncoprotein. J Korean Med Sci. 2000;15:545–50.

    CAS  PubMed  PubMed Central  Google Scholar 

  100. Obaidat NA, Ghazarian DM. Bilateral multiple axillary apocrine hidrocystomas associated with benign apocrine hyperplasia. J Clin Pathol. 2006;59(7):779.

    CAS  PubMed  PubMed Central  Google Scholar 

  101. Hassan MO, Khan MA, Kruse TV. Apocrine cystadenoma. Arch Dermatol. 1979;115:194–200.

    CAS  PubMed  Google Scholar 

  102. Farina MC, Pique E, Olivares M, et al. Multiple hidrocystoma of the face: three cases. Clin Exp Dermatol. 1995;20:323–7.

    CAS  PubMed  Google Scholar 

  103. Xu XL, Zhang GY, Zeng XS, et al. A case of zonal syringocystadenoma papilliferum of the axilla mimicking verruca vulgaris. Am J Dermatopathol. 2010;32(1):49–51.

    PubMed  Google Scholar 

  104. Singh UR. Syringocystadenoma papilliferum mimicking breast carcinoma. Am J Dermatopathol. 2000;22(1):91.

    CAS  PubMed  Google Scholar 

  105. Patterson JW, Straka BF, Wick MR. Linear syringocystadenoma papilliferum of the thigh. J Am Acad Dermatol. 2001;45:139–41.

    CAS  PubMed  Google Scholar 

  106. Ogunrinade K, Blobstein SH, Desman GT. Agminated syringocystadenoma papilliferum: a new clinical presentation of a rare benign adnexal neoplasm. Dermatol Online J. 2013;19(8):19270.

    PubMed  Google Scholar 

  107. Rosen PP, Caicco JA. Florid papillomatosis of the nipple: a study of 51 patients, including nine with mammary carcinoma. Am J Surg Pathol. 1986;10:87–101.

    CAS  PubMed  Google Scholar 

  108. Kunikane H, Ishikura H, Yamaguchi J, et al. Chondroid syringoma (mixed tumor of the skin): a clinicopathologic study of 13 cases. Acta Pathol Jpn. 1987;37:615–25.

    CAS  PubMed  Google Scholar 

  109. Hardisson D, Linares MD, Nistal M. Giant chondroid syringoma of the axilla. J Cutan Med Surg. 1998;3(2):115–7.

    CAS  PubMed  Google Scholar 

  110. Djakovic A, Engel JB, Geisinger E, et al. Pleomorphic adenoma of the breast initially misdiagnosed as metaplastic carcinoma in preoperative stereotactic biopsy: a case report and review of the literature. Eur J Gynaecol Oncol. 2011;32(4):427–30.

    CAS  PubMed  Google Scholar 

  111. Mills SE. Mixed tumor of the skin: a model of divergent differentiation. J Cutan Pathol. 1984;11:382–6.

    CAS  PubMed  Google Scholar 

  112. Kazakov DV, Belousova IE, Bisceglia M, et al. Apocrine mixed tumor of the skin (‘mixed tumor of the folliculosebaceous-apocrine complex’). Spectrum of differentiations and metaplastic changes in the epithelial, myoepithelial, and stromal components based on a histopathologic study of 244 cases. J Am Acad Dermatol. 2007;57:467–83.

    PubMed  Google Scholar 

  113. Dominguez Iglesias F, Fresno Forcelledo F, Soler Sanchez T, et al. Chondroid syringoma: a histological and immunohistochemical study of 15 cases. Histopathology. 1990;17:311–7.

    CAS  PubMed  Google Scholar 

  114. Mambo NC. Hyaline cells in a benign chondroid syringoma. Report of a case and findings by conventional and electron microscopy. Am J Dermatopathol. 1984;6:265–72.

    CAS  PubMed  Google Scholar 

  115. Kazakov DV, Bisceglia M, Spagnolo DV, et al. Apocrine mixed tumors of the skin with architectural and/or cytologic atypia: a retrospective clinicopathologic study of 18 cases. Am J Surg Pathol. 2007;31:1094–102.

    PubMed  Google Scholar 

  116. Mentzel T, Requena L, Kaddu S, et al. Cutaneous myoepithelial neoplasms: clinicopathologic and immunohistochemical study of 20 cases suggesting a continuous spectrum ranging from benign mixed tumor of the skin to cutaneous myoepithelioma and myoepithelial carcinoma. J Cutan Pathol. 2003;30:294–302.

    PubMed  Google Scholar 

  117. Argenyi ZB, Balogh K, Goeken JA. Immunohistochemical characterization of chondroid syringomas. Am J Clin Pathol. 1988;90:662–9.

    CAS  PubMed  Google Scholar 

  118. Hafezi-Bakhtiari S, Al-Habeeb A, Ghazarian D. Benign mixed tumor of the skin, hypercellular variant: a case report. J Cutan Pathol. 2010;37(9):e46–9.

    PubMed  Google Scholar 

  119. Biernat W, Kordek R, Wozniak L. Papillary eccrine adenoma: a case of cutaneous sweat gland tumor with secretory and ductular differentiation. Pol J Pathol. 1994;45:319–22.

    CAS  PubMed  Google Scholar 

  120. Frey J, Shimek C, Woodmansee C, et al. Aggressive digital papillary adenocarcinoma: a report of two diseases and review of the literature. J Am Acad Dermatol. 2009;60:331–9.

    PubMed  Google Scholar 

  121. Bujas T, Pavić I, Lenicek T, et al. Axillary apocrine carcinoma associated with apocrine adenoma and apocrine gland hyperplasia. Acta Dermatovenerol Croat. 2007;15(3):148–51.

    PubMed  Google Scholar 

  122. Tellechea O, Reis JP, Marques C, et al. Tubular apocrine adenoma with eccrine and apocrine immunophenotypes or papillary tubular adenoma? Am J Dermatopathol. 1995;17:499–505.

    CAS  PubMed  Google Scholar 

  123. Chamberlain RS, Huber K, White JC, et al. Apocrine gland carcinoma of the axilla. Review of the literature and recommendations for treatment. Am J Clin Oncol. 1999;22:131–5.

    CAS  PubMed  Google Scholar 

  124. Vandeweyer E, Hubert A, Renard N. Apocrine adenocarcinoma of the nipple: a case report. Acta Chir Belg. 2004;104:476–8.

    CAS  PubMed  Google Scholar 

  125. Miyamoto T, Hagari Y, Inoue S, et al. Axillary apocrine carcinoma with benign apocrine tumours: a case report involving a pathological and immunohistochemical study and review of the literature. J Clin Pathol. 2005;58:757–61.

    CAS  PubMed  PubMed Central  Google Scholar 

  126. Kiyohara T, Kumakiri M, Kawami K, et al. Apocrine carcinoma of the vulva in a band-like arrangement with inflammatory and telangiectatic metastasis via local lymphatic channels. Int J Dermatol. 2003;42:71–4.

    PubMed  Google Scholar 

  127. Warkel RL, Helwig EB. Apocrine gland adenoma and adenocarcinoma of the axilla. Arch Dermatol. 1978;114:198–203.

    CAS  PubMed  Google Scholar 

  128. Paties C, Taccagni GL, Papotti M, et al. Apocrine carcinoma of the skin: a clinicopathologic, immunocytochemical, and ultrastructural study. Cancer. 1993;71:375–81.

    CAS  PubMed  Google Scholar 

  129. Horn RCJR. Malignant papillary cystadenoma of sweat glands with metastases to the regional lymph nodes. Surgery. 1944;16:348–55.

    Google Scholar 

  130. Kazakov DV, Suster S, LeBoit PE, et al. Mucinous carcinoma of the skin, primary, and secondary: a clinicopathologic study of 63 cases with emphasis on the morphologic spectrum of primary cutaneous forms: homologies with mucinous lesions in the breast. Am J Surg Pathol. 2005;29(6):764–82.

    PubMed  Google Scholar 

  131. Laco J, Simáková E, Svobodová J, et al. Recurrent mucinous carcinoma of skin mimicking primary mucinous carcinoma of parotid gland: a diagnostic pitfall. Cesk Patol. 2009;45(3):79–82.

    CAS  PubMed  Google Scholar 

  132. Papalas JA, Proia AD. Primary mucinous carcinoma of the eyelid: a clinicopathologic and immunohistochemical study of 4 cases and an update on recurrence rates. Arch Ophthalmol. 2010;128(9):1160–5.

    PubMed  Google Scholar 

  133. Levy G, Finkelstein A, McNiff JM. Immunohistochemical techniques to compare primary vs. metastatic mucinous carcinoma of the skin. J Cutan Pathol. 2010;37(4):411–5.

    PubMed  Google Scholar 

  134. Rahilly MA, Beattie GJ, Lessells AM. Mucinous eccrine carcinoma of the vulva with neuroendocrine differentiation. Histopathology. 1995;27:82–6.

    CAS  PubMed  Google Scholar 

  135. Ghanadan A, Khosravi M. Cutaneous syringoma: a clinicopathologic study of 34 new cases and review of the literature. Indian J Dermatol. 2013;58(4):326.

    PubMed  PubMed Central  Google Scholar 

  136. Henner MS, Shapiro PE, Ritter JH, et al. Solitary syringoma: a report of five cases and comparison with microcystic adnexal carcinoma. Am J Dermatopathol. 1995;17:465–70.

    CAS  PubMed  Google Scholar 

  137. Furue M, Hori Y, Nakabayashi Y. Clear-cell syringoma: association with diabetes mellitus. Am J Dermatopathol. 1984;6:131–8.

    CAS  PubMed  Google Scholar 

  138. Demirkesen C, Hoede N, Moll R. Epithelial markers and differentiation in adnexal neoplasms of the skin: an immunohistochemical study including individual cytokeratins. J Cutan Pathol. 1995;22(6):518–35.

    CAS  PubMed  Google Scholar 

  139. Lee JH, Chang JY, Lee KH. Syringoma: a clinicopathologic and immunohistologic study and results of treatment. Yonsei Med J. 2007;48(1):35–40.

    PubMed  PubMed Central  Google Scholar 

  140. Kakinuma H, Miyamoto R, Iwasawa U, et al. Three subtypes of poroid neoplasia in a single lesion: eccrine poroma, hidroacanthoma simplex, and dermal duct tumor. Am J Dermatopathol. 1994;16:66–72.

    CAS  PubMed  Google Scholar 

  141. Kircik L, Armus S, Kipping H, et al. Eccrine poroma in an unusual location. Cutis. 1994;54(3):183–4.

    CAS  PubMed  Google Scholar 

  142. Azma A, Tawfik O, Casparian JM. Apocrine poroma of the breast. Breast J. 2001;7(3):195–8.

    CAS  PubMed  Google Scholar 

  143. Sidro-Sarto M, Guimerá-Martin-Neda F, Perez-Robayna N, et al. Eccrine poroma arising in chronic radiation dermatitis. J Eur Acad Dermatol Venereol. 2008;22(12):1517–9.

    CAS  PubMed  Google Scholar 

  144. Pylyser K, DeWolf-Peeters C, Marien K. The histology of eccrine poroma: a study of 14 cases. Dermatologica. 1983;167:243–9.

    CAS  PubMed  Google Scholar 

  145. Tokura Y, Yoshikuni K, Teraki Y, et al. Immunohistochemically detectable duct-like structures in benign and malignant eccrine poromas: CEA and involucrin immunostaining. J Dermatol. 1989;16:133–41.

    CAS  PubMed  Google Scholar 

  146. Takanashi M, Urabe A, Nakayama J, et al. Distribution of epithelial membrane antigen in eccrine poroma. Dermatologica. 1991;183:187–90.

    CAS  PubMed  Google Scholar 

  147. Robson A, Greene J, Ansari N, et al. Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases. Am J Surg Pathol. 2001;25:710–20.

    CAS  PubMed  Google Scholar 

  148. Guldhammer B, Norgaard T. The differential diagnosis of intraepidermal malignant lesions using immunohistochemistry. Am J Dermatopathol. 1986;8:295–301.

    CAS  PubMed  Google Scholar 

  149. Kim JY, Kim YC, Lee ES. Solitary eccrine syringofibroadenoma with prominent plasma cell infiltration. J Dermatol. 2007;34:138–41.

    PubMed  Google Scholar 

  150. de Viragh PA, Meylan R, Montaldi G, et al. Eccrine syringofibroadenoma. Report of clinical aspects and histology of two cases with review of the literature. Hautarzt. 1992;43:724–7.

    PubMed  Google Scholar 

  151. Thomson SA, Rasmussen SA, Zhang J, et al. A new hereditary cylindromatosis family associated with CYLD1 on chromosome 16. Hum Genet. 1999;105:171–3.

    CAS  PubMed  Google Scholar 

  152. Kazakov DV, Soukup R, Mukensnabl P, et al. Brooke-Spiegler syndrome: report of a case with combined lesions containing cylindromatous, spiradenomatous, trichoblastomatous, and sebaceous differentiation. Am J Dermatopathol. 2005;27:27–33.

    PubMed  Google Scholar 

  153. Albores-Saavedra J, Heard SC, McLaren B, et al. Cylindroma (dermal analog tumor) of the breast: a comparison with cylindroma of the skin and adenoid cystic carcinoma of the breast. Am J Clin Pathol. 2005;123(6):866–73.

    PubMed  Google Scholar 

  154. Mahmoud A, Hill DH, O’Sullivan MJ, et al. Cylindroma of the breast: a case report and review of the literature. Diagn Pathol. 2009;4:30.

    PubMed  PubMed Central  Google Scholar 

  155. Mambo NC. Eccrine spiradenomas: clinical and pathologic study of 49 tumors. J Cutan Pathol. 1983;10:312–20.

    CAS  PubMed  Google Scholar 

  156. Lee MW, Kelly JW. Dermal cylindroma and eccrine spiradenoma. Australas J Dermatol. 1996;37:48–9.

    CAS  PubMed  Google Scholar 

  157. Hashimoto K, Dibella RJ, Lever WF. Clear cell hidradenoma: histological, histochemical and electron microscopic studies. Arch Dermatol. 1967;96:18–38.

    CAS  PubMed  Google Scholar 

  158. Angulo J, Jaqueti G, Kutzner H, et al. Squamous cell apocrine hidradenoma. J Cutan Pathol. 2007;34:801–3.

    PubMed  Google Scholar 

  159. Goh SG, Carr R, Dayrit JF, et al. Mucinous hidradenoma: a report of three cases. J Cutan Pathol. 2007;34:497–502.

    PubMed  Google Scholar 

  160. Kazakov DV, Kutzner H, Spagnolo DV, et al. Sebaceous differentiation in poroid neoplasms: report of 11 cases, including a case of metaplastic carcinoma associated with apocrine poroma (sarcomatoid apocrine porocarcinoma). Am J Dermatopathol. 2008;30:21–6.

    PubMed  Google Scholar 

  161. Kazakov DV, Vanecek T, Belousova IE, et al. Skin-type hidradenoma of the breast parenchyma with t(11;19) translocation: hidradenoma of the breast. Am J Dermatopathol. 2007;29:457–61.

    PubMed  Google Scholar 

  162. Laws RA, English JC III, Elston DM. Acrospiroma: a case report and review. Cutis. 1996;58:349–51.

    CAS  PubMed  Google Scholar 

  163. Ohi Y, Umekita Y, Rai Y, et al. Clear cell hidradenoma of the breast: a case report with review of the literature. Breast Cancer. 2007;14(3):307–11.

    PubMed  Google Scholar 

  164. Khurshid A, Yaqoob N, Devan HA, et al. Nuclear grooves in nodular hidradenoma: frequency and significance of an unrecognized histopathological feature. J Cutan Pathol. 2007;34:871–5.

    PubMed  Google Scholar 

  165. Nazarian RM, Kapur P, Rakheja D, et al. Atypical and malignant hidradenomas: a histological and immunohistochemical study. Mod Pathol. 2009;22:600–10.

    CAS  PubMed  Google Scholar 

  166. Nash JW, Barrett TL, Kies M, et al. Metastatic hidradenocarcinoma with demonstration of Her-2/neu gene amplification by fluorescence in situ hybridization: potential treatment implications. J Cutan Pathol. 2007;34(1):49–54.

    PubMed  Google Scholar 

  167. Kazakov DV, Ivan D, Kutzner H, et al. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation. Am J Dermatopathol. 2009;31:236–47.

    PubMed  Google Scholar 

  168. Liapakis IE, Korkolis DP, Koutsoumbi A, et al. Malignant hidradenoma: a report of two cases and review of the literature. Anticancer Res. 2006;26:2217–20.

    CAS  PubMed  Google Scholar 

  169. Souvatzidis P, Sbano P, Mandato F, et al. Malignant nodular hidradenoma of the skin: report of seven cases. J Eur Acad Dermatol Venereol. 2008;22:549–54.

    CAS  PubMed  Google Scholar 

  170. Yavuzer R, Boyaci M, Sari A, et al. Microcystic adnexal carcinoma of the breast: a very rare breast skin tumor. Dermatol Surg. 2002;28:1092–4.

    PubMed  Google Scholar 

  171. Antley CA, Carney M, Smoller BR. Microcystic adnexal carcinoma arising in the setting of previous radiation therapy. J Cutan Pathol. 1999;26:48–50.

    CAS  PubMed  Google Scholar 

  172. Friedman PM, Friedman RH, Jiang B, et al. Microcystic adnexal carcinoma: collaborative series review and update. J Am Acad Dermatol. 1999;41:225–31.

    CAS  PubMed  Google Scholar 

  173. Smith KJ, Williams J, Corbett D, et al. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis. Am J Surg Pathol. 2001;25:464–71.

    CAS  PubMed  Google Scholar 

  174. Hoang MP, Dresser KA, Kapur P, et al. Microcystic adnexal carcinoma: an immunohistochemical approach. Mod Pathol. 2008;21:178–85.

    CAS  PubMed  Google Scholar 

  175. Kawagushi K, Shin SJ. Immunohistochemical staining characteristics of low-grade adenosquamous carcinoma of the breast. Am J Surg Pathol. 2012;36:1009–20.

    Google Scholar 

  176. Geyer FC, Lambros MB, Natrajan R, et al. Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast. Mod Pathol. 2010;23:951–60.

    CAS  PubMed  Google Scholar 

  177. Herrero J, Monteagudo C, Jorda E, et al. Squamoid eccrine ductal carcinoma. Histopathology. 1998;32:478–80.

    CAS  PubMed  Google Scholar 

  178. Terushkin E, Leffell DJ, Futoryan T, et al. Squamoid eccrine ductal carcinoma: a case report and review of the literature. Am J Dermatopathol. 2010;32(3):287–92.

    PubMed  Google Scholar 

  179. Wick MR, Swanson PE. Primary adenoid cystic carcinoma of the skin. Am J Dermatopathol. 1986;8:2–13.

    CAS  PubMed  Google Scholar 

  180. Chang SE, Ahn SJ, Choi JH, et al. Primary adenoid cystic carcinoma of skin with lung metastasis. J Am Acad Dermatol. 1999;40:640–2.

    CAS  PubMed  Google Scholar 

  181. Schwartz LE, Begum S, Westra WH, et al. GATA3 immunohistochemical expression in salivary gland neoplasms. Head Neck Pathol. 2013;7(4):311–5.

    PubMed  PubMed Central  Google Scholar 

  182. Kulkarni N, Pezzi CM, Greif JM, et al. Rare breast cancer: 933 adenoid cystic carcinomas from the National Cancer Data Base. Ann Surg Oncol. 2013;20(7):2236–41.

    PubMed  Google Scholar 

  183. Reyes C, Jorda M, Gomez-Fernández C. Salivary gland-like tumors of the breast express basal-type immunohistochemical markers. Appl Immunohistochem Mol Morphol. 2013;21(4):283–6.

    CAS  PubMed  Google Scholar 

  184. Projetti F, Lacroix-Triki M, Serrano E, et al. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma? J Oral Pathol Med. 2015;44(4):244–51. https://doi.org/10.1111/jop.12226.

    Article  CAS  PubMed  Google Scholar 

  185. Patel KR, Solomon IH, El-Mofty SK, et al. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma. Hum Pathol. 2013;44(11):2501–8.

    CAS  PubMed  Google Scholar 

  186. Ramakrishnan R, Chaudhry IH, Ramdial P, et al. Primary cutaneous adenoid cystic carcinoma: a clinicopathologic and immunohistochemical study of 27 cases. Am J Surg Pathol. 2013;37(10):1603–11.

    PubMed  Google Scholar 

  187. Rocas D, Asvesti C, Tsega A, et al. Primary adenoid cystic carcinoma of the skin metastatic to the lymph nodes: immunohistochemical study of a new case and literature review. Am J Dermatopathol. 2014;36(3):223–8.

    PubMed  Google Scholar 

  188. Park BW, Kim SI, Lee KS, et al. Ductal eccrine carcinoma presenting as a Paget’s disease-like lesion of the breast. Breast J. 2001;7(5):358–62.

    CAS  PubMed  Google Scholar 

  189. Wick MR, Goellner JR, Wolfe JT, et al. Adnexal carcinomas of the skin. I. Eccrine carcinomas. Cancer. 1985;56:1147–62.

    CAS  PubMed  Google Scholar 

  190. Wong TY, Suster S, Mihm MC Jr. Squamoid eccrine ductal carcinoma. Histopathology. 1997;30:288–93.

    CAS  PubMed  Google Scholar 

  191. Urso C, Bondi R, Paglierani M, et al. Carcinomas of sweat glands: report of 60 cases. Arch Pathol Lab Med. 2001;125:498–505.

    CAS  PubMed  Google Scholar 

  192. Swanson PE, Mazoujian G, Mills SE, et al. Immunoreactivity for estrogen receptor protein in sweat gland tumors. Am J Surg Pathol. 1991;15:835–41.

    CAS  PubMed  Google Scholar 

  193. Brownstein MH, Helwig EB. Patterns of cutaneous metastasis. Arch Dermatol. 1972;105:862–8.

    CAS  PubMed  Google Scholar 

  194. Lloyd J, Flanagan AM. Mammary and extramammary Paget’s disease. J Clin Pathol. 2000;53:742–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  195. Chaundary MA, Millis RR, Lane B, et al. Paget’s disease of the nipple: a ten-year review including clinical, pathological, and immunohistochemical findings. Breast Cancer Res Treat. 1986;8:139–46.

    Google Scholar 

  196. Mazoujian G, Pinkus GS, Haagensen DE. Extramammary Paget’s disease: evidence for an apocrine origin. Am J Surg Pathol. 1984;8:43–50.

    CAS  PubMed  Google Scholar 

  197. Regauer S. Extramammary Paget’s disease—a proliferation of adnexal origin? Histopathology. 2006;48:723–9.

    CAS  PubMed  Google Scholar 

  198. Nadji M, Morales AR, Girtanner RE, et al. Paget’s disease of the skin: a unifying concept of histogenesis. Cancer. 1982;50:2203–6.

    CAS  PubMed  Google Scholar 

  199. Ojeda VJ, Heenen PJ, Watson SH. Paget’s disease of the groin associated with adenocarcinoma of the urinary bladder. J Cutan Pathol. 1987;14:227–31.

    CAS  PubMed  Google Scholar 

  200. Minicozzi A, Borzellino G, Momo R, et al. Perianal Paget’s disease: presentation of six cases and literature review. Int J Color Dis. 2010;25(1):1–7.

    Google Scholar 

  201. Ansai S, Hashimoto H, Aoki T, et al. A histochemical and immunohistochemical study of extra-ocular sebaceous carcinoma. Histopathology. 1993;22(2):127–33.

    CAS  PubMed  Google Scholar 

  202. Misago N, Toda S, Hikichi Y, et al. A unique case of extramammary Paget’s disease. Derivation from eccrine porocarcinoma? Am J Dermatopathol. 1992;14(6):553–9.

    CAS  PubMed  Google Scholar 

  203. Chiu CS, Yang CH, Chen CH. Extramammary Paget’s disease of the unilateral axilla: a review of seven cases in a 20-year experience. Int J Dermatol. 2011;50(2):157–60.

    PubMed  Google Scholar 

  204. Guarner J, Cohen C, Derose PB. Histogenesis of extramammary and mammary Paget’s cells. Am J Dermatopathol. 1989;11:313–8.

    CAS  PubMed  Google Scholar 

  205. Russell-Jones R, Spaull J, Gusterson B. The histogenesis of mammary and extramammary Paget’s disease. Histopathology. 1989;14:409–16.

    Google Scholar 

  206. Lundquist K, Kohler S, Rouse RV. Intraepidermal cytokeratin 7 expression is not restricted to Paget’s cells but it is also seen in Toker cells and Merkel cells. Am J Surg Pathol. 1999;23:212–9.

    CAS  PubMed  Google Scholar 

  207. Fitzpatrick JE. The histologic diagnosis of intraepithelial pagetoid neoplasms. Clin Dermatol. 1991;9:255–9.

    CAS  PubMed  Google Scholar 

  208. Helm KF, Goellner JR, Peters MS. Immunohistochemical stains in extramammary Paget’s disease. Am J Dermatopathol. 1992;14:402–7.

    CAS  PubMed  Google Scholar 

  209. Yoneda K. Immunohistochemical staining properties of keratin type intermediate filaments in mammary and extra-mammary Paget’s disease. J Dermatol. 1989;16:47–53.

    CAS  PubMed  Google Scholar 

  210. Reed W, Oppedal BR, Eeglarsen T. Immunohistology is valuable in distinguishing between Paget’s disease, Bowen’s disease and superficial spreading malignant melanoma. Histopathology. 1990;16:583–8.

    CAS  PubMed  Google Scholar 

  211. Yanai H, Takahashi N, Omori M, Oda W, et al. Immunohistochemistry of p63 in primary and secondary vulvar Paget’s disease. Pathol Int. 2008;58(10):648–51.

    PubMed  Google Scholar 

  212. Díaz de León E, Carcangiu ML, Prieto VG, et al. Extramammary Paget’s disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently express androgen receptor. Am J Clin Pathol. 2000;113:572–5.

    PubMed  Google Scholar 

  213. Horn LC, Purz S, Krumpe C, et al. COX-2 and Her-2/neu are overexpressed in Paget’s disease of the vulva and the breast: results of a preliminary study. Arch Gynecol Obstet. 2008;277:135–8.

    CAS  PubMed  Google Scholar 

  214. Liegl B, Horn LC, et al. Androgen receptors are frequently expressed in mammary and extramammary Paget’s disease. Mod Pathol. 2005;18:1283–8.

    CAS  PubMed  Google Scholar 

  215. Lammie GA, Barnes DM, Millis RR, et al. An immunohistochemical study of the presence of c-erbB-2 protein in Paget’s disease of the nipple. Histopathology. 1989;15:505–14.

    CAS  PubMed  Google Scholar 

  216. Tanskanen M, Jahkola T, Asko-Seljavaara S, et al. HER2 oncogene amplification in extramammary Paget’s disease. Histopathology. 2003;42:575–9.

    CAS  PubMed  Google Scholar 

  217. Alzaraa A, Thomas GD, Vodovnik A, et al. Merkel cell carcinoma in a male breast: a case report. Breast J. 2007;13(5):517–9.

    PubMed  Google Scholar 

  218. Pulitzer MP, Amin BD, Busam KJ. Merkel cell carcinoma: review. Adv Anat Pathol. 2009;16(3):135–44.

    PubMed  Google Scholar 

  219. Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319:1096–100.

    CAS  PubMed  PubMed Central  Google Scholar 

  220. Hachana M, Trimeche M, Ziadi S, et al. Evidence for a role of the Simian Virus 40 in human breast carcinomas. Breast Cancer Res Treat. 2009;113:43–58.

    CAS  PubMed  Google Scholar 

  221. Hachana M, Amara K, Ziadi S, et al. Investigation of human JC and BK polyomaviruses in breast carcinomas. Breast Cancer Res Treat. 2012;133(3):969–77.

    CAS  PubMed  Google Scholar 

  222. Khan G, Philip PS, Naase M, et al. No evidence for the involvement of XMRV or MCV in the pathogenesis of breast cancer. Br J Cancer. 2012;106(6):1166–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  223. Antonsson A, Bialasiewicz S, Rockett RJ, et al. Exploring the prevalence of ten polyomaviruses and two herpes viruses in breast cancer. PLoS One. 2012;7(8):e39842. https://doi.org/10.1371/journal.pone.0039842.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  224. Stetsenko GY, Malekirad J, Paulson KG. p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility. Am J Clin Pathol. 2013;140(6):838–84.

    PubMed  Google Scholar 

  225. Daoud MA, Mete O, Al Habeeb A, et al. Neuroendocrine carcinoma of the skin—an updated review. Semin Diagn Pathol. 2013;30(3):234–44.

    PubMed  Google Scholar 

  226. Christie M, Chin-Lenn L, Watts MM, et al. Primary small cell carcinoma of the breast with TTF-1 and neuroendocrine marker expressing carcinoma in situ. Int J Clin Exp Pathol. 2010;3(6):629–33.

    PubMed  PubMed Central  Google Scholar 

  227. Shin SJ, DeLellis RA, Ying L, et al. Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients. Am J Surg Pathol. 2000;24(9):1231–8.

    CAS  PubMed  Google Scholar 

  228. Sangoi AR, Cassarino DS. PAX-8 expression in primary and metastatic Merkel cell carcinoma: an immunohistochemical analysis. Am J Dermatopathol. 2013;35(4):448–51.

    PubMed  Google Scholar 

  229. Nonaka D, Chiriboga L, Soslow RA. Expression of PAX8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol. 2008;32(10):1566–71.

    PubMed  Google Scholar 

  230. Woodard AH, Yu J, Dabbs DJ, et al. NY-BR-1 and PAX8 immunoreactivity in breast, gynecologic tract, and other CK7+ carcinomas: potential use for determining site of origin. Am J Clin Pathol. 2011;136(3):428–35.

    PubMed  Google Scholar 

  231. Augustsson A. Melanocytic nevi, melanoma and sun exposure. Acta Derm Venereol. 1991;166(Suppl):1–34.

    CAS  Google Scholar 

  232. Elder DE, Jucovy P, Tuthill RJ, et al. The classification of melanoma. Am J Dermatopathol. 1980;2:315–20.

    CAS  PubMed  Google Scholar 

  233. Pawlik TM, Ross MI, Prieto VG, et al. Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma. Cancer. 2006;106:900–6.

    PubMed  Google Scholar 

  234. Quinn MJ, Crotty KA, Thompson JF, et al. Desmoplastic and desmoplastic neurotropic melanoma. Experience with 280 patients. Cancer. 1998;83:1128–35.

    CAS  PubMed  Google Scholar 

  235. Gonzáles S, Duarte I. Benign fibrous histiocytoma of the skin. A morphologic study of 290 cases. Pathol Res Pract. 1982;172:379–91.

    Google Scholar 

  236. Cerio R, Spaull J, Wilson JE. Histiocytoma cutis: a tumor of dermal dendrocytes (dermal dendrocytoma). Br J Dermatol. 1989;120:197–206.

    CAS  PubMed  Google Scholar 

  237. Bandarchi B, Ma L, Marginean C, et al. D2–40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans. Mod Pathol. 2010;23:434–8.

    CAS  PubMed  Google Scholar 

  238. Kuwano H, Hashimoto H, Enjoji M. Atypical fibroxanthoma distinguishable from spindle cell carcinoma in sarcoma-like skin lesions. A clinicopathologic and immunohistochemical study of 21 cases. Cancer. 1985;55(1):172–80.

    CAS  PubMed  Google Scholar 

  239. Luzar B, Calonje E. Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls: a review. J Cutan Pathol. 2010;7:301–9.

    Google Scholar 

  240. Ang GC, Roenigk RK, Otley CC, et al. More than 2 decades of treating atypical fibroxanthoma at Mayo Clinic: what we have learned from 91 patients? Dermatol Surg. 2009;5:765–72.

    Google Scholar 

  241. Datubo-Brown DD. Keloids: a review of the literature. Br J Plast Surg. 1990;43:70–7.

    CAS  PubMed  Google Scholar 

  242. Requena L, Gutiérrez J, Sánchez YE. Multiple sclerotic fibromas of the skin—a cutaneous marker of Cowden’s disease. J Cutan Pathol. 1991;19:346–51.

    Google Scholar 

  243. Mahmood MN, Salama ME, Chaffins M, et al. Solitary sclerotic fibroma of skin: a possible link with pleomorphic fibroma with immunophenotypic expression for O13 (CD99) and CD34. J Cutan Pathol. 2003;30:631–6.

    PubMed  Google Scholar 

  244. Fletcher CDM, Evans BJ, Macartney JC, et al. Dermatofibrosarcoma protuberans: a clinicopathological and immunohistochemical study with a review of the literature. Histopathology. 1985;9:921–38.

    CAS  PubMed  Google Scholar 

  245. Yeniay L, Unalp O, Sezak M, et al. Dermatofibrosarcoma protuberans of the breast. Breast J. 2012;18(5):493–4.

    PubMed  Google Scholar 

  246. Green JJ, Heymann WR. Dermatofibrosarcoma protuberans occurring in a smallpox vaccination scar. J Am Acad Dermatol. 2003;48:S54–5.

    PubMed  Google Scholar 

  247. Parlette LE, Smith CK, Germain LM, et al. Accelerated growth of dermatofibrosarcoma protuberans during pregnancy. J Am Acad Dermatol. 1999;41:778–83.

    CAS  PubMed  Google Scholar 

  248. Wacker J, Khan-Durani B, Hartschuh W. Modified Mohs’ micrographic surgery in the therapy of dermatofibrosarcoma protuberans: analysis of 22 patients. Ann Surg Oncol. 2004;11:438–44.

    PubMed  Google Scholar 

  249. Sirvent N, Maire G, Pedeutour F. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer. 2003;37:1–19.

    CAS  PubMed  Google Scholar 

  250. Aiba S, Tabata N, Ishii H, et al. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34. Br J Dermatol. 1992;172:79–84.

    Google Scholar 

  251. Brathwaite C, Suster S. Dermatofibrosarcoma protuberans. A critical reappraisal of the role of immunohistochemical stains for diagnosis. Appl Immunohistochem. 1994;2:36–41.

    Google Scholar 

  252. Labonte S, Hanna W, Bandarchi-Chamkhaleh B. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma. J Cutan Pathol. 2007;34:857–60.

    PubMed  Google Scholar 

  253. Cribier B, Noacco G, Peltre B, et al. Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans. J Am Acad Dermatol. 2002;46:408–13.

    PubMed  Google Scholar 

  254. Mentzel T, Kutzner H. Dermatomyofibroma: clinicopathological and immunohistochemical analysis of 56 cases and reappraisal of a rare and distinct cutaneous neoplasm. Am J Dermatopathol. 2009;31:44–9.

    PubMed  Google Scholar 

  255. Ng WK, Cheung MF, Ma L. Dermatomyofibroma: further support of its myofibroblastic nature by electron microscopy. Histopathology. 1996;29:181–3.

    CAS  PubMed  Google Scholar 

  256. Slipman N, Harrist T, Rhodes A. Congenital arrector pili hamartoma. A case and review of the spectrum of Becker’s melanosis and pilar smooth muscle hamartoma. Arch Dermatol. 1985;211:1034–7.

    Google Scholar 

  257. Yokoyama R, Hashimoto H, Daimaru Y, et al. Superficial leiomyomas. A clinicopathologic study of 34 cases. Acta Pathol Jpn. 1987;37:1415–22.

    CAS  PubMed  Google Scholar 

  258. Argenyi ZB, Piette WW, Goeken J. Cutaneous angiomyolipoma. Am J Dermatopathol. 1991;13:497–502.

    CAS  PubMed  Google Scholar 

  259. Jensen ML, Jensen OM, Michalski W, et al. Intradermal and subcutaneous leiomyosarcoma: a clinicopathological and immunohistochemical study of 41 cases. J Cutan Pathol. 1996;23:458–63.

    CAS  PubMed  Google Scholar 

  260. Pijpe J, Broers GH, Plaat BE, et al. The relation between histological, tumor-biological and clinical parameters in deep and superficial leiomyosarcoma and leiomyoma. Sarcoma. 2002;6:105–10.

    CAS  PubMed  PubMed Central  Google Scholar 

  261. Usmani N, Merchant W, Yung A. A case of cutaneous symplastic leiomyoma—a rare variant of cutaneous pilar leiomyoma. J Cutan Pathol. 2008;35:329–31.

    PubMed  Google Scholar 

  262. Fox SB, Heryet A, Khong TY. Angioleiomyomas: an immunohistological study. Histopathology. 1990;16:495–6.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Garrett Desman

  2. Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Garrett Desman

  3. Dermatopathology Division, Optum Care, New Hyde Park, NY, USA

    Garrett Desman

  4. Integrated Pathology Services, Trujillo Alto, Puerto Rico

    Lurmag Y. Orta

  5. Hospital Auxilio Mutuo, San Juan, Puerto Rico

    Lurmag Y. Orta

  6. Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY, USA

    Sandra J. Shin

Authors
  1. Garrett Desman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lurmag Y. Orta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sandra J. Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sandra J. Shin .

Editor information

Editors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY, USA

    Sandra J. Shin

  2. Department of Pathology, University of California San Francisco, San Francisco, CA, USA

    Yunn-Yi Chen

  3. Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA

    Paula S. Ginter

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Desman, G., Orta, L.Y., Shin, S.J. (2022). Dermatologic Mimickers of Breast Lesions Arising in the Breast Skin, Subcutis, or Axilla. In: Shin, S.J., Chen, YY., Ginter, P.S. (eds) A Comprehensive Guide to Core Needle Biopsies of the Breast . Springer, Cham. https://doi.org/10.1007/978-3-031-05532-4_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-05532-4_25

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-05531-7

  • Online ISBN: 978-3-031-05532-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation